Guidelines : Hypersalivation in adults
Detail
Condition :
Hypersalivation in adults
Keywords :
amitriptyline, ipratropium bromide, hyoscine hydrobromide, Scopaderm, procyclidine, atropine eye drops, trihexyphenidyl, benzhexol, glycopyrronium bromide, Colonis, botulinum toxin A, Xeomin, Parkinson's disease, MND, MS, post CVA, acquired brain injury, neurodisability, cerebral palsy, long term ventilation, drooling, drug-induced hypersalivation, sialorrhea, botox
BNF Codes :
Committee Recommendations
Date
Committee Name
Narrative
Traffic Light Status
06 January 2021
The Surrey Heartlands Integrated Care System Area Prescribing Committee have updated and approved the Pharmacological Management of Hypersalivation in Adults treatment pathway and associated atropine Patient Information Leaflet (PIL). They have been updated to clarify that atropine minims can be kept for 24 hours once opened - see guidance and PIL documents below
N/A
Documents
Type
Document
Review Date
NICE Technology Appraisal
Patient resource
January 2023
Supplementary documents (CCG specific documents)
No records returned.
Drugs
Below are listed drugs that are used to treat Hypersalivation in adults.
- Amitriptyline Green
- Atropine Blue
- Glycopyrronium bromide Blue
- Hyoscine hydrobromide Green (see narrative)
- Ipratropium Green (see narrative)
- Procyclidine Blue
- Trihexyphenidyl Blue